The goal of the Nuclear Magnetic Resonance (NMR) Shared Resource at the Purdue University Cancer Center is to provide essential NMR services to Cancer Center investigators. These services include providing sample analysis on nine spectrometers and expert assistance to researchers in setting up and interpreting NMR experiments. The funds requested will support this essential resource for Cancer Center members who use NMR in their research. Currently, at least 20 principal investigators with peer reviewed funding make extensive use of the Facility. Specific cancer research areas that utilize the NMR shared resource include: I) Examination of cellular processes involved in human cancer. NMR is used to obtain mechanistic and structural information about proteins and enzymes involved in cell transformation. 2) Studies of the mechanisms of action of anticancer drugs. 3) Development of synthetic routes to known and new anti-cancer agents. NMR is an absolute requirement for the synthetic and drug discovery programs targeted to increase the supply of known anticancer compounds as well as -to devise new compounds. NMR is used to monitor the course of reactions and to determine the structure of these complex synthetic molecules. The NMR Shared Resource provides state of the art NMR equipment and services for cancer researchers at Purdue University. This Facility is critical for the successful completion of many diverse cancer-related research projects and provides a necessary service in efforts to understand and treat cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023168-23
Application #
6469207
Study Section
Project Start
2001-07-01
Project End
2002-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
23
Fiscal Year
2001
Total Cost
$216,966
Indirect Cost
Name
Purdue University
Department
Type
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Onel, Buket; Carver, Megan; Agrawal, Prashansa et al. (2018) The 3'-end region of the human PDGFR-? core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes. Biochim Biophys Acta Gen Subj 1862:846-854
Sorlien, Erin L; Witucki, Mary A; Ogas, Joseph (2018) Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio. J Vis Exp :
Mani, Saravana Kumar Kailasam; Andrisani, Ourania (2018) Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine :
Dong, Cheng; Dong, Guangping; Li, Li et al. (2018) An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2. Commun Biol 1:183
Morman, Rosemary E; Schweickert, Patrick G; Konieczny, Stephen F et al. (2018) BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice. Eur J Immunol 48:1492-1505
Zhang, Zhuangzhuang; Cheng, Lijun; Li, Jie et al. (2018) Inhibition of the Wnt/?-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Cancer Res 78:3147-3162
Rangasamy, Loganathan; Chelvam, Venkatesh; Kanduluru, Ananda Kumar et al. (2018) New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange. Bioconjug Chem 29:1047-1059
Zhang, Hao; Zhang, Yanqiu; Zhu, Xiaoyun et al. (2018) DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1. Hepatology :
Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985
Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112

Showing the most recent 10 out of 436 publications